Free · Tool
Bloodwork Panel Planner
Plan consolidated blood work panels based on your peptide research protocol. Get recommended biomarkers, testing frequency, and lab panel suggestions organized by protocol phase — baseline, mid-cycle, and post-cycle.
Select your peptides and protocol phase to generate a consolidated bloodwork panel with reference ranges, cost estimates, and a testing timeline.
1
Select Your Peptides
2
Select Protocol Phase
Baseline
Before starting
Mid-Protocol
4–6 weeks in
Post-Protocol
2–4 weeks after stopping
Bloodwork Panel — Signal IQ
3
Your Consolidated Panel
| Test | Required By | Reference Range | What to Watch | Est. Cost |
|---|
Testing Timeline
General
Male
Female
| Marker | Normal Range | Unit | Notes |
|---|
Want help interpreting your results? Chat with Pulse, Signal IQ’s free AI research assistant — ask about any biomarker, reference range, or what a change between draws might mean.
Research & educational use only. This planner provides general biomarker and testing-frequency information for peptide research protocols. It is not medical advice, a diagnosis, or a substitute for guidance from a licensed clinician. Reference ranges vary by laboratory — always confirm results with your provider. Signal IQ does not sell peptides.
Frequently Asked Questions
What bloodwork do I need before peptides?
Baseline bloodwork before starting peptides typically includes a Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC), Lipid Panel, and category-specific markers. GH peptides require IGF-1, GLP-1 agonists need HbA1c and pancreatic enzymes, and hormonal peptides require a full hormone panel including Total/Free Testosterone, Estradiol, LH, FSH, and SHBG. Use the planner above to generate your exact panel based on the peptides you plan to research.
How often should I get blood work on peptides?
Best practice is three phases: Baseline (before starting), Mid-Protocol (4–6 weeks in) to assess response and safety markers, and Post-Protocol (2–4 weeks after stopping) to confirm recovery. Some markers like liver enzymes and blood glucose may warrant more frequent monitoring if abnormalities are detected during the mid-protocol check.
What does IGF-1 tell me about GH peptides?
IGF-1 (Insulin-like Growth Factor 1) is the primary biomarker for assessing growth hormone secretagogue effectiveness. Since GH is released in pulses and has a short half-life, IGF-1 provides a more stable measure of overall GH activity. A rising IGF-1 from baseline indicates the GH peptide is successfully stimulating growth hormone release. Target ranges are typically 200–350 ng/mL for adults, though optimal levels vary by age and individual goals.